Komen Foundation Announces African American Women’s Initiative

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 3
Volume 8
Issue 3

DALLAS-The Susan G. Komen Breast Cancer Foundation has launched the African American Women’s Initiative (AAWI), a landmark effort to create a national standard for African American breast health education.

DALLAS—The Susan G. Komen Breast Cancer Foundation has launched the African American Women’s Initiative (AAWI), a landmark effort to create a national standard for African American breast health education.

The goal of the AAWI is to reduce the high breast cancer mortality among African American women. “We have long recognized the need to address this important issue,” said Nancy Brinker, founding chairman of the Foundation.

The AAWI is represented by a national advisory committee made up of experts and thoughtleaders from the African American community, including Zora Kramer Brown, president and founder of the Breast Cancer Resource Committee; Nadine Eads, community outreach director at Washington Hospital Center, Washington, DC; and Noma Roberson, director of community intervention research at Roswell Park Cancer Institute.

The top priority of the AAWI is to identify breast health education and outreach programs that are making an impact on the African American community and can be replicated nationwide.

“The key to success is to design programs that reflect the needs of African American women and effectively communicate the life-saving message of early detection,” Mrs. Brinker said. “But we don’t have to start from scratch.” Currently, the Foundation funds several such programs, including the Witness Project, a national program that enlists African American breast cancer survivors to share their stories with women at their local churches; the East-West Breast Express, which educates women at public transportation sites in Atlanta and Oakland, Calif; and the Patient Navigator Program at Harlem Hospital Center, New York, which matches women with patient advocates who navigate them through diagnosis to treatment and beyond.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.